SEC 13F Intelligence

Mpm Bioimpact LLC / DBVT

Mpm Bioimpact LLC’s Dbv Technologies S A Position

Does Mpm Bioimpact LLC own Dbv Technologies S A (DBVT)? Yes — 5.21M shares worth $109M (+8.41% of its 13F portfolio) as of Q1 2026, up from 996.8K shares the prior filed quarter.

Position Value
$109M
Q1 2026
Shares
5.21M
% of Portfolio
+8.41%
Quarters Held
4
currently held

Position History DBVT

Reported value by quarter
Q2 ’25: $10MQ2 ’25Q3 ’25: $11MQ3 ’25Q4 ’25: $19MQ4 ’25Q1 ’26: $109MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20265.21M$109M+8.41%
Q4 2025996.8K$19M+2.19%
Q3 20251.05M$11M+1.73%
Q2 20251.05M$10M+1.67%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mpm Bioimpact LLC’s full portfolio or all institutional holders of DBVT.